Search research articles
Contact Us
Filters
Showing results (1141-1150 of 1,298) with videos related to
Page
of 130
Sort By:
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
September 22, 2018
The Emergency Medicine Specimen Bank: An Innovative Approach To Biobanking In Acute Care
Jessica L Saben, Shelby K Shelton, Andrew J Hopkinson, et al.
Cancer Research
|
August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Cancer Cell
|
February 29, 2020
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
Daniel J McGrail, Jeannine Garnett, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 2016
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance
Katrien Berns, Amir Sonnenblick, Annemiek Gennissen, et al.
Cancer Research
|
September 10, 2017
ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma
Abibatou Ndoye, Anna Budina-Kolomets, Curtis H Kugel, et al.
Breast Cancer Research : BCR
|
November 3, 2020
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Ana C Garrido-Castro, Cristina Saura, Romualdo Barroso-Sousa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2021
Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal Cancer
Jonathan M Loree, Yucai Wang, Muddassir A Syed, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 27, 2022
Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer
Rourou Xiao, Lixin You, Li Zhang, et al.
Cancer Research
|
June 28, 2014
Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer
Yi-Hsin Hsu, Jun Yao, Li-Chuan Chan, et al.
Cell
|
May 5, 2022
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer
Xiulei Mo, Qiankun Niu, Andrey A Ivanov, et al.
Page
of 130
Search research articles
Search
Showing results (1141-1150 of 1,298) with videos related to
Sort By:
Page
of 130
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
September 22, 2018
The Emergency Medicine Specimen Bank: An Innovative Approach To Biobanking In Acute Care
Jessica L Saben, Shelby K Shelton, Andrew J Hopkinson, et al.
Cancer Research
|
August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Cancer Cell
|
February 29, 2020
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
Daniel J McGrail, Jeannine Garnett, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 2016
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance
Katrien Berns, Amir Sonnenblick, Annemiek Gennissen, et al.
Cancer Research
|
September 10, 2017
ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma
Abibatou Ndoye, Anna Budina-Kolomets, Curtis H Kugel, et al.
Breast Cancer Research : BCR
|
November 3, 2020
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Ana C Garrido-Castro, Cristina Saura, Romualdo Barroso-Sousa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2021
Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal Cancer
Jonathan M Loree, Yucai Wang, Muddassir A Syed, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 27, 2022
Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer
Rourou Xiao, Lixin You, Li Zhang, et al.
Cancer Research
|
June 28, 2014
Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer
Yi-Hsin Hsu, Jun Yao, Li-Chuan Chan, et al.
Cell
|
May 5, 2022
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer
Xiulei Mo, Qiankun Niu, Andrey A Ivanov, et al.
Page
of 130